The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCPR.L Regulatory News (CPR)

  • There is currently no data for CPR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (OPD) - Carpetright plc

4 Nov 2019 14:45

Meditor Capital Management Ltd - Form 8 (OPD) - Carpetright plc

Meditor Capital Management Ltd - Form 8 (OPD) - Carpetright plc

PR Newswire

London, November 4

FORM 8 (OPD)

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:Meditor Capital Management Limited (“MCML”).
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.Meditor European Master Fund Limited (“MEMFL”) is the beneficial owner of the relevant securities. Both it and MCML are subsidiaries of Meditor Group Limited. MCML is discretionary investment advisor to MEMFL.
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeCarpetright plc.
(d) Is the discloser the offeror or the offeree?The offeror is MEMFL.
(e) Date position held: The latest practicable date prior to the disclosure1 November 2019.
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A”No.

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

Class of relevant security:
InterestsShort positions
Number%Number%
(1) Relevant securities owned and/or controlled:91,097,24129.99
(2) Cash-settled derivatives:
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:
TOTAL:91,097,24129.99

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

(b) Rights to subscribe for new securities

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

Details of any interests, short positions and rights to subscribe (including directors’ and other employee options) of any person acting in concert with the party to the offer making the disclosure:

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state “none”
None

(c) Attachments

Are any Supplemental Forms attached?

Supplemental Form 8 (Open Positions)NO
Supplemental Form 8 (SBL)NO

Date of disclosure:4 November 2019
Contact name:T. Shakerchi
Telephone number:01372467779

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Date   Source Headline
21st Aug 201411:35 amRNSDirector's Other Directorships
14th Aug 201410:10 amRNSHolding(s) in Company
13th Aug 20142:32 pmRNSDirector/PDMR Shareholding
12th Aug 20145:07 pmRNSAdditional Listing
4th Aug 20143:57 pmRNSHolding(s) in Company
1st Aug 20142:01 pmRNSDirector/PDMR Shareholding
1st Aug 201411:34 amRNSAnnual Financial Report
31st Jul 20142:25 pmRNSDirector/PDMR Shareholding
31st Jul 201411:20 amRNSTotal Voting Rights
29th Jul 20147:00 amRNSInterim Management Statement
16th Jul 20145:29 pmRNSDirector/PDMR Shareholding
16th Jul 201412:52 pmRNSDirectorate Change
9th Jul 20142:45 pmRNSDirector/PDMR Shareholding
24th Jun 20147:01 amRNSDirectorate Change
24th Jun 20147:00 amRNSFinal Results
13th Jun 20143:50 pmRNSDirector/PDMR Shareholding
5th Jun 20142:48 pmRNSDirector Declaration
2nd Jun 20143:04 pmRNSDirector/PDMR Shareholding
30th May 20142:00 pmRNSTotal Voting Rights
21st May 20147:00 amRNSManagement Succession and Board Changes
16th May 20142:54 pmRNSHolding(s) in Company
13th May 201411:58 amRNSDirector/PDMR Shareholding
1st May 20145:14 pmRNSDirector's Other Directorships
30th Apr 20141:41 pmRNSTotal Voting Rights
16th Apr 20144:37 pmRNSDirector/PDMR Shareholding
7th Apr 20142:36 pmRNSDirector/PDMR Shareholding
2nd Apr 201411:08 amRNSDirector/PDMR Shareholding
28th Mar 20142:56 pmRNSHolding(s) in Company
26th Mar 20147:00 amRNSTrading Statement
21st Mar 20147:00 amRNSOFT consultation on advertising of prices
21st Mar 20147:00 amRNSOFT closes investigation into retailers
13th Mar 20144:58 pmRNSDirector/PDMR Shareholding
5th Mar 20141:54 pmRNSRe: Pre Close Trading Update
5th Mar 20141:41 pmRNSHolding(s) in Company
4th Mar 201411:38 amRNSHolding(s) in Company
13th Feb 20145:21 pmRNSDirector/PDMR Shareholding
6th Feb 20145:02 pmRNSDirector/PDMR Shareholding
28th Jan 20147:00 amRNSInterim Management Statement
15th Jan 201411:01 amRNSDirector/PDMR Shareholding
13th Jan 20143:48 pmRNSDirector/PDMR Shareholding
2nd Jan 20144:47 pmRNSDirector/PDMR Shareholding
30th Dec 20134:03 pmRNSTotal Voting Rights
27th Dec 20135:00 pmRNSHolding(s) in Company
17th Dec 201311:16 amRNSHolding(s) in Company
17th Dec 201311:09 amRNSHolding(s) in Company
17th Dec 201311:00 amRNSDirector/PDMR Shareholding
13th Dec 20131:40 pmRNSDirector/PDMR Shareholding
12th Dec 201311:51 amRNSDirector/PDMR Shareholding
10th Dec 20137:00 amRNSHalf Yearly Report
29th Nov 20134:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.